Finsbury Orthopaedics / DePuy Orthopaedics Inc.
Cavendish Corporate Finance LLP is pleased to announce the sale of Finsbury Orthopaedics Ltd , the UK based manufacturer and global distributor of orthopaedic implants, to DePuy Orthopaedics Inc. The financial terms of the sale have not been disclosed.
Finsbury Orthopaedics, based in Leatherhead, has pioneered advanced high performance, large diameter hip bearings that feature proprietary ceramic-on-ceramic and metal-on-metal bearing technologies designed to address the unmet needs of active patients.
Finsbury’s key products include the DeltaMotion® Ceramic-on-Ceramic Hip System, the ADEPT® Metal-on-Metal Hip Resurfacing and Total Hip System, as well as the Medial Rotation Knee System, the Dual Bearing Knee System, the BOX® Total Ankle Replacement, Tuke Saw and multiple small joint reconstructive implant lines.
DePuy Orthopaedics, Inc., a Johnson & Johnson company, is a leading global provider of orthopaedic devices for hip, knee, extremities, and trauma, as well as bone cement and operating room products. It is part of the DePuy Family of Companies, which has a rich heritage of pioneering a broad range of products and solutions across the continuum of orthopaedic and neurological care.
Cavendish has been advising Finsbury for several years, commencing with a consulting exercise focusing on mapping the route to a successful exit and culminating in a highly targeted sale exercise involving the world’s leading major orthopaedic players, based primarily in Europe and the USA.
Hugo Haddon-Grant , the Cavendish partner who led the sale, commented:
“We are delighted to announce the successful sale of Finsbury Orthopaedics in what are challenging market conditions. The outcome proves the huge potential of the product portfolio built up by Finsbury as well as the ability of Cavendish to manage a highly competitive sale process with multinational buyers and to deliver value today for future potential. We are confident that DePuy will provide the best platform for the successful development and marketing of Finsbury’s world class portfolio of products going forward.”
“We’re excited to be joining the Calibre Scientific family, who will enable us to further accelerate our long-term strategic growth objectives. The finnCap Cavendish team has achieved a fantastic result for our Shareholders. Their wealth of sector expertise, professionalism and unwavering dedication throughout the process were instrumental in achieving a successful completion.”
‘finnCapCavendish have great international connections and were able to bring an Australian buyer in the patient flow software sector to us. Their tenacity and understanding of the deal dynamics enabled us to run a smooth process and sell Extramed to a strategic buyer.’
“The team at Cavendish have done a fantastic job advising the Board of Zenith. They were confident that there would be strong overseas interest in the business and they managed that interest extremely professionally. We are delighted with the outcome and look forward to the next chapter for Zenith.”
“The Cavendish Team, led by Michael Jewell, did an excellent job managing a well-orchestrated auction process and ensuring the smooth closing of the transaction in a timely manner. They were professional and easy to deal with throughout and committed to achieving a successful outcome for the shareholders.”
I am very pleased to have found such a complementary match in Venture Life, a highly successful consumer healthcare group with a reputation for accelerating the growth of the brands it acquires.
The resources and expertise of Venture Life will see Periproducts on a trajectory of rapid growth under the guidance of a proven management team, through enhanced marketing opportunities, new product development and, crucially, access to a substantial number of export markets.The Cavendish team were of great assistance throughout the sale process and in particular finding us the most fitting acquirer, helped by their strong networks in healthcare and their understanding of the oral care market.
“We are delighted to partner with Bridgepoint who will help take MVF to the next level. Bridgepoint has proved to be the perfect match for MVF because they understand the company vision and culture and have the financial capability and international reach to support the continued growth of the business.
We made absolutely the right choice in appointing Cavendish. Michael Jewell and the team were instrumental in getting us the deal we wanted. I would have no hesitation in recommending them to anyone thinking about a sales process.”
I wanted to express my personal thanks to you for all your efforts in achieving a successful sale of Yorktest. I never knew how stressful and complex the sale process could be. I really do appreciate your finding a good deal in quite difficult circumstances.
The Cavendish Team, led by Michael Jewell, did an excellent job managing a well-orchestrated auction process and ensuring the smooth closing of the transaction in a timely manner. They were professional and easy to deal with throughout and committed to achieving a successful outcome for the shareholders.
Cavendish’s Exit Review allowed us to align and mobilize all stakeholders on the key priorities that have the most impact on valuation over a 6-18 month period – a very valuable exercise.
Thank you so much for your efforts and teamwork in selling RPS! Your approach and process was vital to our successful sale of the Company. In particular, the initiation of a excellent and professional process enabled us to get the actual sales process launched and resourced effectively, which facilitated the smooth initiation of selling discussions in a thorough manner.
Recent Deals for Healthcare Sector
Avicenna Holdings Limited
Juno Health Limited
Pollet Medical Group
Femme Laboratorioda Mulher